Leaflet: information for the patient
Etoricoxib pensa 30 mg film-coated tablets
Etoricoxib pensa 60 mg film-coated tablets
Etoricoxib pensa 90 mg film-coated tablets
Etoricoxib pensa 120 mg film-coated tablets
Read this leaflet carefully before you start taking this medicine, as it contains important information for you.
1. What isEtoricoxibpensaand what it is used for
2. What you need to know before starting to takeEtoricoxibpensa
3. How to takeEtoricoxibpensa
4. Possible side effects
5. Storage ofEtoricoxibpensa
6. Contents of the pack and additional information
What is Etoricoxib?
What is Etoricoxib used for?
What is osteoarthritis?
Osteoarthritis is a disease of the joints. It causes the gradual breakdown of the cartilage that cushions the ends of the bones. This causes swelling (inflammation), pain, sensitivity, stiffness, and disability.
What is rheumatoid arthritis?
Rheumatoid arthritis is a long-term inflammatory disease of the joints. It causes pain, stiffness, swelling, and progressive loss of mobility in the affected joints. It also causes inflammation in other areas of the body.
What is gout?
Gout is a disease of sudden and recurrent attacks of very painful and inflamed joints. It is caused by deposits of mineral crystals in the joint.
What is ankylosing spondylitis?
Ankylosing spondylitis is an inflammatory disease of the spine and long joints.
Do not take Etoricoxib:
Etoricoxib may slightly increase your risk of heart attack and stroke, and therefore should not be used in patients who have had heart problems or a stroke.
If you think you fall into any of these cases, do not take the tablets until you have consulted your doctor.
Warnings and precautions
Consult your doctor or pharmacist before starting to take Etoricoxib if:
If you are unsure whether any of the above situations affect you,talk to your doctor before taking this medicineto check if etoricoxib is suitable for you.
Etoricoxib works just as well in young adults and children. If you are over 65years of age, your doctor will want to keep a close eye on you. No adjustment of the dose is needed in patients over 65years of age.
Children and adolescents
Do not administer this medicine to children and adolescents under 16years of age.
Taking Etoricoxib with other medicines
Inform your doctor or pharmacist if you are using, have used recently or may need to use any other medicine, including those bought without a prescription.
In particular, if you are using any of the following medicines, your doctor may want to monitor you to check that your medicines are working properly once you start taking Etoricoxib:
Etoricoxib can be taken withlow dosesof aspirin. If you are currently taking low doses of aspirin to prevent heart attacks or strokes, do not stop taking aspirin until you have spoken with your doctor
do not takehigh dosesof aspirin or other anti-inflammatory medicines while taking this medicine.
Taking Etoricoxib with food and drink
The onset of Etoricoxib's effect may be faster if taken without food.
Pregnancy, breastfeeding and fertility
Pregnancy
Etoricoxib tablets should not be taken during pregnancy. Do not take the tablets if you are pregnant, if you think you may be pregnant or if you are planning to become pregnant. If you become pregnant, stop taking the tablets and consult your doctor. Consult your doctor if you have any doubts or need more information.
Breastfeeding
We do not know if Etoricoxib is excreted in breast milk. If you are breastfeeding or plan to do so, consult your doctor before taking Etoricoxib. If you are using this medicine, do not breastfeed.
Fertility
We do not recommend using Etoricoxib in women who are trying to become pregnant.
Driving and operating machinery
In some patients taking Etoricoxib, dizziness and somnolence have been reported.
Do not drive if you experience dizziness or somnolence.
Do not use tools or machinery if you experience dizziness or somnolence.
Follow exactly the administration instructions of this medication as indicated by your doctor. In case of doubt, consult your doctor or pharmacist again.
Do not take more than the recommended dose for your condition. Your doctor will want to discuss your treatment from time to time. It is essential to use the lowest dose that controls your pain and do not take Etoricoxib for longer than necessary. This is because the risk of myocardial infarction and stroke could increase after prolonged treatment, especially with high doses.
There are different doses available for this medication, and depending on your condition, your doctor will prescribe the tablet with the dose that is suitable for you.
The recommended dose is:
Osteoarthritis
The recommended dose is 30mg once a day, increasing up to a maximum of 60mg once a day if necessary.
Rheumatoid arthritis
The recommended dose is 60mg once a day, increasing up to a maximum of 90mg once a day if necessary.
Ankylosing spondylitis
The recommended dose is 60mg once a day, increasing up to a maximum of 90mg once a day if necessary.
Acute pain situations
Etoricoxib should only be used during the period of acute pain.
Gout
The recommended dose is 120mg once a day, which should only be used during the period of acute pain, limited to a maximum of 8days of treatment.
Postoperative pain after dental surgery
The recommended dose is 90mg once a day, limited to a maximum of 3days of treatment.
Patients with liver problems
Use in children and adolescents
Children or adolescents under 16years of age should not take Etoricoxib tablets.
Patients over 65years
No dose adjustment is necessary for patients over 65years. As with other medications, caution should be exercised in elderly patients.
Administration form
This medication is administered orally. Take the tablets once a day. Etoricoxib can be taken with or without food.
If you take more Etoricoxib than you should
You should never take more tablets than your doctor recommends. If you take too many Etoricoxib tablets, seek medical attention immediately.
In case of overdose or accidental ingestion, you can also call the Toxicological Information Service, Tfno. 91 562 04 20, indicating the medication and the amount taken. It is recommended to bring the packaging and the medication leaflet to the healthcare professional.
If you forgot to take Etoricoxib
It is essential to take this medication as your doctor has indicated. If you forget a dose, limit yourself to resuming the usual regimen the next day.Do not take a double dose to compensate for the missed doses.
If you have any other doubts about the use of this medication, ask your doctor or pharmacist.
Like all medicines, this medicine can cause side effects, although not everyone will experience them.
If you develop any of these signs, stop takingthis medicineand talk to your doctor immediately (see section2.What you need to know before starting to takeEtoricoxib):
The frequency of possible side effects listed below is defined according to the following convention:
Very common (may affect more than 1 in 10 people)
Common (may affect up to 1 in 10 people)
Uncommon (may affect up to 1 in 100 people)
Rare (may affect up to 1 in 1,000 people)
Very rare (may affect up to 1 in 10,000 people)
The following side effects may occur during treatment withEtoricoxib:
Very common:
Common::
Uncommon::
Rare::
Reporting of side effects:
If you experience any type of side effect, consult your doctor or pharmacist, even if it is a possible side effect that does not appear in this leaflet. You can also report them directly through the Spanish System for the Pharmacovigilance of Medicines for Human Use:https://www.notificaram.es. By reporting side effects, you can contribute to providing more information on the safety of this medicine.
Keep this medication out of the sight and reach of children.
Do not use this medication after the expiration date that appears on the packaging after CAD. The expiration date is the last day of the month indicated.
Store in the original packaging to protect it from moisture.
Medications should not be disposed of through drains or trash. Dispose of the packaging and unused medications at the SIGRE point of the pharmacy. If in doubt, ask your pharmacist how to dispose of unused packaging and medications. By doing so, you will help protect the environment.
Composition of Etoricoxib pensa
Core of the tablet:microcrystalline cellulose (E460), calcium hydrogen phosphate, croscarmellose sodium and magnesium stearate (E470b).
Coating of the tablet:
Appearance of the product and contents of the package
Film-coated tablet.
Etoricoxib pensa 30 mg film-coated tablets EFG:
Blue-green film-coated tablets, apple-shaped and biconvex, engraved with “30” on one side and smooth on the other, with dimensions of 5.8 x 5.9 mm+7.5%.
Etoricoxib pensa 60 mg film-coated tablets EFG:
Dark green film-coated tablets, apple-shaped and biconvex, engraved with “60” on one side and smooth on the other, with dimensions of 7.1 x 7.3 mm+7.5%.
Etoricoxib pensa 90 mg film-coated tablets EFG:
White film-coated tablets, apple-shaped and biconvex, engraved with “90” on one side and smooth on the other, with dimensions of 8.1 x 8.3 mm+7.5%.
Etoricoxib pensa 120 mg film-coated tablets EFG:
Light green film-coated tablets, apple-shaped and biconvex, engraved with “120” on one side and smooth on the other, with dimensions of 8.9 x 9.2 mm+7.5%.
Etoricoxib pensa is presented in perforated unit-dose blisters.
Pack sizes:
30 mg:
7, 20 and 28 film-coated tablets.
60 mg:
7, 20 and 28 film-coated tablets.
90 mg:
7, 20 and 28 film-coated tablets.
120 mg:
5, 7 and 28 film-coated tablets.
Only some pack sizes may be marketed.
Marketing Authorization Holder:
Towa Pharmaceutical, S.A.
C/ de Sant Martí, 75-97
08107 Martorelles (Barcelona)
Spain
Manufacturer:
Rontis Hellas Medical and Pharmaceutical Products S.A.
P.O. Box 3012 Larisa Industrial Area, Larisa 41004 Greece
This medicinal product is authorized in the member states of the European Economic Area with the following names:
Portugal: Etoricoxib toLife 30mg, 60mg, 90mg, 120mg film-coated tablets
Italy: Etoricoxib Pensa 30mg, 60mg, 90mg, 120mg film-coated tablets
Spain: Etoricoxib pensa 30mg, 60mg, 90mg and 120mg film-coated tablets EFG
Last revision date of thisleaflet:December 2016
Further information on this medicinal product is available on the website of the Spanish Agency of Medicines and Medical Devices (AEMPS) (http://www.aemps.gob.es/)
Have questions about this medication or your symptoms? Connect with a licensed doctor for guidance and personalized care.